As of Wednesday close, Boston Scientific Corporation’s (NYSE:BSX) stock was up $0.35, moving up 0.80 percent to $43.89. The average number of shares traded per day over the past five days has been 4,293,020 shares. 5 times new highs have been achieved over the past 5 days, with a $0.91 gain in that time frame. In the last twenty days, the average volume was 6,685,760, while in the previous 50 days, it was 7,344,860.
Since last month, BSX stock rose 6.27%. Shares of the company fell to $40.58 on 10/24/22, the lowest level in the past month. A 52-week high of $47.49 was reached on 04/20/22 after having rallying from a 52-week low of $34.98. Since the beginning of this year, BSX’s stock price has risen by 3.32% or $1.41, and marked a new high 6 times. However, the stock has declined by -7.59% since its 52-week high.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
BSX stock investors should be aware that Boston Scientific Corporation (BSX) stock had its last reported insider trading activity 7 days ago on Nov 18. Thepaut Eric Francis Yves, the EVP & Pres, Eur, Mid-East, Afr of the company, disposed of 14,952 shares for $42.72 on Nov 18. It resulted in a $638,773 divestment by the insider. Carruthers Wendy sold 1,678 shares at an average price of $42.60 on Nov 15. The insider now owns 94,913 shares following the transaction. On Nov 07, Chairman, President & CEO Mahoney Michael F sold 125,827 shares at $41.97 apiece. The transaction was valued at $5,280,997.
Right now, Boston Scientific Corporation (BSX) has a P/E ratio of about 105.76. The stock’s beta is 0.85. Besides these, the trailing price-to-sales (P/S) ratio of 4.91, the price-to-book (PB) ratio of 3.56, and the price-to-cash flow ratio of 111.26 may also be considered.
In the three months ended September 29, Boston Scientific Corporation’s quick ratio stood at 0.90, while its current ratio was 1.40, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.49, and the total debt-to-equity ratio was 0.49. On the profitability front, the trailing twelve-month gross margin is 68.90% percent. In the year ended September 29, operating margins totaled 9.80%. Based on annual data, BSX earned $8.18 billion in gross profit and brought in $11.89 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 4.50%. Return on equity (ROE) for the past 12 months was 3.50%.
In Boston Scientific Corporation’s quarter-end financial report for September 29, it reported total debt of $8.56 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. BSX’s revenue rose 7.51% to $3.24 billion during the quarter, while net income inched up to $3.17 billion. While analysts expected Boston Scientific Corporation to report $0.44 quarterly earnings, the actual figure was $0.43 per share, beating the consensus estimate by -2.30%. During the quarter, the company generated $767.0 million in EBITDA. The liabilities of Boston Scientific Corporation were 14.31 billion at the end of its most recent quarter ended September 29, and its total debt was $9.33 billion. The value of shareholders’ equity is $1.43 billion.
This quick technical analysis looks at Boston Scientific Corporation’s (BSX) price momentum. With a historical volatility rate of 23.48%, the RSI 9-day stood at 65.85% on 23 November.
With respect to its five-day moving average, the current Boston Scientific Corporation price is up by +2.12% percent or $0.91. At present, BSX shares trade +5.03% above its 20-day simple moving average and +16.23% percent above its 100-day simple moving average. However, the stock is currently trading approximately +4.33% above its SMA50 and -0.61% below its SMA200.
Stochastic coefficient K was 83.77% and Stochastic coefficient D was 72.20%, while ATR was 1.00. Given the Stochastic reading of 97.35% for the 14-day period, the RSI (14) reading has been calculated as 62.63%. As of today, the MACD Oscillator reading stands at 0.60, while the 14-day reading stands at 0.82.